Oncolytics Biotech Financials - Benzinga

Oncolytics Biotech Inc

ONCYNASDAQ

Trade with Public

Trade with Public

$0.6630

-0.0203-2.97%

À la clôture: Sep 28, 5:00 PM EST

$0.6762

0.01321.99%

Après les heures: 7:40 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Rapport sur les stocks

Oncolytics Biotech Financials

Oncolytics Biotech (ONCY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Oncolytics Biotech Q2 EPS $(0.05) Beats $(0.10) Estimate

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50.5 percent. This is a 28.57 percent increase over losses of $(0.07) per share from

Benzinga Newsdesk

Earnings Scheduled For August 8, 2025

Benzinga Insights

What to Expect from Oncolytics Biotech's Earnings

Benzinga Insights

PRO
Oncolytics Biotech Q1 EPS $(0.06) Beats $(0.09) Estimate

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 14.29 percent increase over losses of $(0.07) per share

Benzinga Newsdesk

Earnings Scheduled For May 14, 2025

Benzinga Insights

A Look at Oncolytics Biotech's Upcoming Earnings Report

Benzinga Insights

© 2026 Benzinga | All Rights Reserved